(Sharecast News) - Pfizer reported stronger-than-expected first-quarter results on Tuesday and reaffirmed its full-year guidance, as growth from older blockbusters and recently launched or acquired medicines offset another sharp fall in Covid product sales.
The US drugmaker said revenue rose 5% year on year to $14.45bn, ahead of Wall Street expectations...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE